Ilex Medical Ltd (TLV:ILX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 5,500.00
-29.00 (-0.52%)
Apr 29, 2026, 3:55 PM IDT
Ilex Medical Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 619 | 746 | 842 | 663 | 1,081 | 1,834 | Upgrade
|
| Market Cap Growth | -15.77% | -11.47% | 27.01% | -38.64% | -41.07% | 32.20% | Upgrade
|
| Enterprise Value | 430 | 550 | 716 | 555 | 926 | 1,705 | Upgrade
|
| Last Close Price | 55.29 | 64.44 | 70.75 | 54.58 | 86.89 | 142.18 | Upgrade
|
| PE Ratio | 11.13 | 13.43 | 21.61 | 13.04 | 10.58 | 9.29 | Upgrade
|
| PS Ratio | 0.66 | 0.80 | 0.92 | 0.72 | 1.25 | 1.73 | Upgrade
|
| PB Ratio | 0.90 | 1.09 | 1.30 | 1.06 | 1.76 | 3.19 | Upgrade
|
| P/TBV Ratio | 0.93 | 1.12 | 1.35 | 1.11 | 1.86 | 3.34 | Upgrade
|
| P/FCF Ratio | 13.48 | 16.25 | 16.24 | 20.95 | 24.79 | 7.98 | Upgrade
|
| P/OCF Ratio | 8.49 | 10.24 | 10.32 | 8.25 | 15.50 | 6.78 | Upgrade
|
| EV/Sales Ratio | 0.46 | 0.59 | 0.78 | 0.61 | 1.07 | 1.61 | Upgrade
|
| EV/EBITDA Ratio | 4.64 | 6.17 | 7.41 | 4.44 | 4.72 | 5.75 | Upgrade
|
| EV/EBIT Ratio | 9.52 | 9.86 | 11.40 | 7.17 | 6.33 | 6.93 | Upgrade
|
| EV/FCF Ratio | 9.37 | 11.99 | 13.80 | 17.52 | 21.25 | 7.42 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.07 | 0.08 | 0.08 | 0.08 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 0.45 | 0.45 | 0.47 | 0.39 | 0.26 | 0.20 | Upgrade
|
| Debt / FCF Ratio | 1.01 | 1.01 | 0.99 | 1.52 | 1.18 | 0.26 | Upgrade
|
| Net Debt / Equity Ratio | -0.28 | -0.28 | -0.29 | -0.27 | -0.28 | -0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.11 | -2.11 | -1.92 | -1.35 | -0.89 | -0.76 | Upgrade
|
| Net Debt / FCF Ratio | -4.11 | -4.11 | -3.58 | -5.33 | -3.99 | -0.98 | Upgrade
|
| Asset Turnover | 0.94 | 0.94 | 0.92 | 0.96 | 0.97 | 1.28 | Upgrade
|
| Inventory Turnover | 4.08 | 4.08 | 4.43 | 4.51 | 4.43 | 5.39 | Upgrade
|
| Quick Ratio | 1.99 | 1.99 | 1.88 | 1.86 | 2.11 | 2.12 | Upgrade
|
| Current Ratio | 2.83 | 2.83 | 2.68 | 2.46 | 2.81 | 2.63 | Upgrade
|
| Return on Equity (ROE) | 8.35% | 8.35% | 7.20% | 8.98% | 18.25% | 38.76% | Upgrade
|
| Return on Assets (ROA) | 3.51% | 3.51% | 3.90% | 5.05% | 10.31% | 18.60% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.58% | 8.74% | 10.17% | 12.98% | 28.15% | 55.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.60% | 7.60% | 8.60% | 10.50% | 21.70% | 38.80% | Upgrade
|
| Earnings Yield | 8.98% | 7.45% | 4.63% | 7.67% | 9.45% | 10.77% | Upgrade
|
| FCF Yield | 7.42% | 6.15% | 6.16% | 4.77% | 4.03% | 12.53% | Upgrade
|
| Dividend Yield | 3.56% | 3.08% | 1.72% | 2.50% | 2.21% | 3.74% | Upgrade
|
| Payout Ratio | 24.56% | 24.56% | 39.16% | 42.14% | 58.75% | 30.38% | Upgrade
|
| Buyback Yield / Dilution | - | - | 0.02% | 0.79% | 0.02% | -5.73% | Upgrade
|
| Total Shareholder Return | 3.56% | 3.08% | 1.74% | 3.29% | 2.22% | -1.98% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.